| Developers: | eKuore Medical Devices |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
2022: Announcement of electronic stethoscope for remote health monitoring of patients with chronic diseases
In October 2022, the company Avivir"" launched sales of an electronic stethoscope from a Spanish company. eKuore Medical Devices The device is intended for remote monitoring of the health status of patients with chronic diseases, as well as for examination if suspected. COVID-19 Capabilities of the device:
- Increases volume
- Connects to the earphone using the connector
- Connects to a hearing aid
- Connects to a smartphone
- Records and allows you to forward auscultations.
According to the developers, cardiologists and neurologists reduce the number of medical consultations, allows collecting more objective data between consultations. Thanks to the device, pediatricians allow you to get involved in the diagnostic process, and students and universities - to observe and listen to auscultation in real time, up to 3 patients at once, improves academic performance and understanding.
The eKuore Pro stethoscope can connect to wireless and wired headphones and hearing aids, and also allows you to increase the volume, unlike standard stethoscopes. In addition, an ordinary stethoscope requires contact with a patient (less than 50 cm between doctor and patient), which increases the risk of contracting coronavirus infection COVID-19. Listening using eKuore Pro is performed remotely: the stethoscope can be connected via Bluetooth to wireless headphones or speakers using a special mobile application, and the results of auscultation are automatically recorded in the medical history.
The cost of eKuore Pro is 45 thousand rubles. By October 17, 2022, the device is available for medical organizations and doctors, and in the future it will retail.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |